Clinical trial targets aging reversal for vision loss

Fox News correspondent Alexandria Hoff has the latest on efforts to secure the 'fountain of youth' on 'Special Report.'

Bret Baier highlights a groundbreaking clinical trial targeting age-related vision loss using gene therapy. The treatment aims to reprogram cells to act younger, potentially leading to broader aging reversal solutions. The segment explores increasing interest in longevity science, including efforts by tech entrepreneur Bryan Johnson and Russian President Vladimir Putin's quest for extended lifespan.